Literature DB >> 4940962

L-asparaginase induced immunosuppression: inhibition of bone marrow derived antibody precursor cells.

H Friedman.   

Abstract

The cooperation between bone marrow and thymus cells in restoring the hemolytic antibody response to sheep erythrocytes in immunosuppressed recipients was markedly inhibited when donor mice were treated with L-asparaginase, a known inhibitor of lymphocyte function. The marrow cell population was shown to be a major target for the immunosuppressive activity of asparaginase, since thymus cells from enzyme-treated animals interacted with marrow cells from normal animals to generate immunocompetent cells.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4940962     DOI: 10.1126/science.174.4005.139

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

Review 1.  Suppression of the immune response by microorganisms.

Authors:  J H Schwab
Journal:  Bacteriol Rev       Date:  1975-06

2.  Differential asparaginase sensitivity of T-cell and B-cell responses.

Authors:  M C Berenbaum; W A Cope; W Jeffery
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

3.  Biochemical properties of yeast L-asparaginase.

Authors:  G E Jones; R K Mortimer
Journal:  Biochem Genet       Date:  1973-06       Impact factor: 1.890

4.  L-asparaginase and in vitro lymphocyte blastogenesis. Cell membrane alteration as possible mechanism of inhibitory effect.

Authors:  T Han; T Onuma
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

Review 5.  Glutamine as indispensable nutrient in oncology: experimental and clinical evidence.

Authors:  Katharina S Kuhn; Maurizio Muscaritoli; Paul Wischmeyer; Peter Stehle
Journal:  Eur J Nutr       Date:  2009-11-21       Impact factor: 5.614

Review 6.  Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis).

Authors:  Julian Banerji
Journal:  Int J Mol Med       Date:  2015-07-15       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.